Overview

LifeMine Therapeutics searches for new medicines by mining genetically-encoded small molecules (GEMs) from nature, especially fungi. Its drug discovery engine combines gigascale DNA sequencing, artificial intelligence, and synthetic biology to explore the biosphere in a digital way and identify promising GEMs that can become drugs. The company moves from large-scale data on biosynthetic genes to lead compounds that may treat hard-to-solve diseases. Unlike many firms that design chemicals in a lab, LifeMine focuses on naturally inspired molecules recovered from fungal genomes and uses a dedicated genome repository to guide discovery, which helps it find novel medicines that work in new ways. The goal is to commercialize these newly discovered drugs to address medical needs previously unmet by existing therapies.